{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:52:21Z","timestamp":1784663541831,"version":"3.55.0"},"reference-count":25,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["10\/400"],"award-info":[{"award-number":["10\/400"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007598","name":"Accident Compensation Corporation","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/100007598","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Randomized controlled trials have suggested that vitamin D supplementation can prevent asthma and chronic obstructive pulmonary disease (COPD) exacerbations. For COPD, the benefit appears to be limited to individuals with baseline 25-hydroxyvitamin D (25OHD) levels &lt;25 nmol\/L. We performed a post hoc analysis of data from a randomized, double-blinded, placebo-controlled trial to investigate the effect that monthly, high-dose vitamin D supplementation (versus placebo) had on older adults with asthma and\/or COPD. Specifically, we investigated whether vitamin D supplementation prevented exacerbations of these conditions. Participants were randomly assigned either to an initial oral dose of 200,000 IU vitamin D3 followed by 100,000 IU monthly or to placebo, with an average follow-up period of 3.3 years. Among the 5110 participants, 775 had asthma or COPD at the beginning of the study, and were eligible for inclusion in this analysis. Exacerbations were defined by the prescription of a short-burst of oral corticosteroids. The mean age of the participants was 67 years old, and 56% were male. The mean baseline blood 25OHD level was 63 nmol\/L; 2.3% were &lt;25 nmol\/L. Overall, we found that vitamin D supplementation did not affect the exacerbation risk (hazard ratio 1.08; 95%CI 0.84\u20131.39). Among those with baseline 25OHD &lt;25 nmol\/L, however, the hazard ratio was 0.11 (95%CI 0.02\u20130.51); p for interaction = 0.001. Although monthly vitamin D supplementation had no overall impact on risk of exacerbations of asthma or COPD, we found evidence of a probable benefit among those with severe vitamin D deficiency.<\/jats:p>","DOI":"10.3390\/nu13020521","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T14:07:40Z","timestamp":1612706860000},"page":"521","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Effect of Monthly Vitamin D Supplementation on Preventing Exacerbations of Asthma or Chronic Obstructive Pulmonary Disease in Older Adults: Post Hoc Analysis of a Randomized Controlled Trial"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5071-7654","authenticated-orcid":false,"suffix":"Jr.","given":"Carlos A.","family":"Camargo","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9375-8608","authenticated-orcid":false,"given":"Les","family":"Toop","sequence":"additional","affiliation":[{"name":"Department of General Practice, University of Otago, Christchurch 8140, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9722-139X","authenticated-orcid":false,"given":"John","family":"Sluyter","sequence":"additional","affiliation":[{"name":"School of Population Health, University of Auckland, Auckland 1142, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlene M. M.","family":"Lawes","sequence":"additional","affiliation":[{"name":"School of Population Health, University of Auckland, Auckland 1142, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4627-8342","authenticated-orcid":false,"given":"Debbie","family":"Waayer","sequence":"additional","affiliation":[{"name":"School of Population Health, University of Auckland, Auckland 1142, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Tee","family":"Khaw","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 2QQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian R.","family":"Martineau","sequence":"additional","affiliation":[{"name":"Institute for Population Health Sciences, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0013-2620","authenticated-orcid":false,"given":"Robert","family":"Scragg","sequence":"additional","affiliation":[{"name":"School of Population Health, University of Auckland, Auckland 1142, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Alshabanat, A., Zafari, Z., Albanyan, O., Dairi, M., and Fitzgerald, J.M. (2015). Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0136065"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S115-32","DOI":"10.1513\/AnnalsATS.201503-151AW","article-title":"Pathogenesis of Viral Infection in Exacerbations of Airway Disease","volume":"12","author":"Ritchie","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_3","unstructured":"Global Initiative for Asthma (GINA) (2020, October 30). Global strategy for asthma management and prevention. Available online: http:\/\/www.ginasthma.com\/."},{"key":"ref_4","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2020, October 30). Global strategy for the diagnosis, management, and prevention of COPD. Available online: http:\/\/www.goldcopd.com\/."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"i6583","DOI":"10.1136\/bmj.i6583","article-title":"Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data","volume":"356","author":"Martineau","year":"2017","journal-title":"BMJ"},{"key":"ref_6","unstructured":"Feldman, D., Pike, J.W., Bouillon, R., Giovannucci, E., Goltzman, D., and Hewison, M. (2018). Vitamin D, acute respiratory infection, and asthma\/chronic obstructive pulmonary disease. Vitamin D, Elsevier Academic Press. [4th ed.]."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S2213-2600(17)30306-5","article-title":"Vitamin D supplementation to prevent asthma exacerbations: A systematic review and meta-analysis of individual participant data","volume":"5","author":"Jolliffe","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/thoraxjnl-2018-212092","article-title":"Vitamin D to prevent exacerbations of COPD: Systematic review and meta-analysis of individual participant data from randomised controlled trials","volume":"74","author":"Jolliffe","year":"2019","journal-title":"Thorax"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-156-2-201201170-00004","article-title":"High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: A randomized trial","volume":"156","author":"Lehouck","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S2213-2600(14)70255-3","article-title":"Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): A multicentre, double-blind, randomised controlled trial","volume":"3","author":"Martineau","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.2147\/COPD.S132117","article-title":"Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: A pilot trial","volume":"12","author":"Rafiq","year":"2017","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_12","first-page":"243","article-title":"Effects of Vitamin D Intake on FEV1 and COPD Exacerbation: A Randomized Clinical Trial Study","volume":"7","author":"Zendehdel","year":"2014","journal-title":"Glob. J. Heal. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jsbmb.2015.09.010","article-title":"The Vitamin D Assessment (ViDA) Study: Design of a randomized controlled trial of vitamin D supplementation for the prevention of cardiovascular disease, acute respiratory infection, falls and non-vertebral fractures","volume":"164","author":"SScragg","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/jamacardio.2017.0175","article-title":"Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study: A Randomized Clinical Trial","volume":"2","author":"Scragg","year":"2017","journal-title":"JAMA Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S2213-8587(17)30103-1","article-title":"Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: Secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial","volume":"5","author":"Khaw","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/cid\/ciz801","article-title":"Effect of Monthly High-Dose Vitamin D Supplementation on Acute Respiratory Infections in Older Adults: A Randomized Controlled Trial","volume":"71","author":"Camargo","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3945\/ajcn.112.054502","article-title":"Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: The Multi-Ethnic Study of Atherosclerosis","volume":"97","author":"Sachs","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1503\/cmaj.091784","article-title":"Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care","volume":"182","author":"Hill","year":"2010","journal-title":"Can. Med Assoc. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1513\/AnnalsATS.201506-388OC","article-title":"Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality","volume":"12","author":"Martinez","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.clnu.2018.07.034","article-title":"Monthly high-dose vitamin D3 supplementation and self-reported adverse events in a 4-year randomized controlled trial","volume":"38","author":"Malihi","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/ajcn\/nqy378","article-title":"Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: Results from a randomized controlled trial","volume":"109","author":"Malihi","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sassi, F., Tamone, C., and D\u2019Amelio, P. (2018). Vitamin D: Nutrient, Hormone, and Immunomodulator. Nutrients, 10.","DOI":"10.3390\/nu10111656"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1111\/febs.15534","article-title":"Vitamin D to prevent COVID-19: Recommendations for the design of clinical trials","volume":"287","author":"Camargo","year":"2020","journal-title":"FEBS J."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/2\/521\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:20:22Z","timestamp":1760160022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/2\/521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,6]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["nu13020521"],"URL":"https:\/\/doi.org\/10.3390\/nu13020521","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,6]]}}}